醫療設備比例閥市場：按閥門類型、驅動方式、流量、應用和最終用戶分類－2026-2032年全球預測

預計到 2025 年，醫療設備比例閥市場價值將達到 14.1 億美元，到 2026 年將成長至 16.1 億美元，到 2032 年將達到 37.5 億美元，複合年成長率為 14.97%。

主要市場統計數據
基準年 2025	14.1億美元
預計年份：2026年	16.1億美元
預測年份 2032	37.5億美元
複合年成長率 (%)	14.97%

比例閥如何重新定義醫療設備中的精確流體控制，並在臨床環境中建立新的性能標準。

比例閥在現代醫療設備設計中扮演著日益重要的角色，其對流體、氣體和壓力的精確控制能夠顯著提升患者照護並提高器械可靠性。致動器技術和控制電子技術的進步，使得人們對比例閥的反應速度、可重複性和與封閉回路型臨床系統的整合度提出了更高的要求。隨著臨床操作對精度要求的不斷提高，以及監管機構對安全性和可追溯性的日益重視，比例閥的功能定位正從單純的組件轉變為系統級的關鍵部件。

數位化整合、更嚴格的法規以及跨學科工程的融合正在重塑比例閥領域，帶來變革性的變化。

在比例閥領域，技術、監管和商業性等多個方面正同時發生變革性的變化。數位控制架構的引入正將閥門從類比致動器轉向網實整合元件，從而實現軟體驅動的校準、遠距離診斷和自適應控制迴路，進而提高臨床響應速度。同時，材料科學的微型化和進步使得閥門能夠在保持生物相容性和耐滅菌性的前提下，整合到更小的尺寸中。

2025 年美國關稅變動對醫療閥門製造商的供應鏈、籌資策略和零件冗餘的累積影響。

美國2025年實施的關稅調整政策對比例閥生產和分銷的供應鏈產生了實際的影響。某些進口零件的成本差異導致製造商重新評估零件籌資策略，迫使他們審查材料清單（BOM）分配、近岸外包機會以及供應商合約條款，以維持成本的可預測性。某些進口子零件成本壓力的增加也影響了策略供應商的議價動態，促使他們簽訂包含風險分擔條款和聯合庫存緩衝的長期合約。

將閥門類型、應用領域、操作模式、最終用戶環境和流量等級與臨床性能聯繫起來的實用細分分析。

以細分市場為中心的觀點闡明了設計意圖、臨床背景和最終用戶環境如何影響比例閥的技術和商業性決策。根據閥門類型，設計團隊通常區分流量控制閥、減壓閥和安全閥，每種閥門都有不同的性能優先級，例如線性度、響應時間和過壓特性。這些功能差異會影響材料選擇、控制演算法的複雜性和檢驗通訊協定，進而決定臨床環境中需要緩解的故障模式類型。

區域趨勢和優先事項（北美和南美、歐洲、中東和非洲、亞太地區）影響分銷選擇和監管一致性。

區域趨勢對比例閥調節技術的研發時機、供應商生態系統、臨床導入路徑均有顯著影響。在美洲，採購週期中，供應彈性、臨床證據包和交易透明度往往是優先考慮的因素，這使得能夠展現出健全的品質系統、快速技術支援和可靠物流的供應商更具優勢。而在歐洲、中東和非洲，通常要求嚴格遵守當地法規結構並提供統一的技術文檔，這迫使供應商維護全面的合規記錄並投資於上市後監測能力。

領先比例閥開發公司的競爭資訊：重點關注產品差異化、供應彈性、策略夥伴關係和生命週期支援。

比例閥開發或整合企業之間的競爭取決於它們能否將技術差異化、運行可靠性和可擴展的支援相結合。主要企業強調精確控制、低功耗驅動方案以及符合無菌和生物相容性要求的檢驗材料。同樣重要的是，供應商能否提供詳細的技術資料包、軟體介面和長期生命週期支持，這可以減輕原始設備製造商 (OEM) 的整合負擔，並最大限度地減少監管方面的阻力。

關鍵的營運、採購和研發舉措，旨在幫助醫療設備領導者快速將創新的比例閥技術整合到臨床產品中。

產業領導者必須將技術知識轉化為具體的營運和策略行動，以確保臨床部署和商業性永續性。首先，透過制定跨職能需求規範，使工程規範與優先臨床應用案例保持一致，這些規範應納入臨床醫師、採購部門和品質保證部門的意見。這可以減少後期重新設計，並加快檢驗。其次，透過對關鍵組件實施雙源採購或經認證的第二供應商策略，並透過快速認證通訊協定儘早檢驗替代方案，從而降低對單一供應商的依賴風險。

結合技術檢驗、相關人員訪談和供應鏈追蹤的穩健混合調查方法，確保了準確性和可操作的見解。

本分析的調查方法結合了多種混合方法，以確保技術嚴謹性和實際應用價值。作為初步調查，我們對設備工程師、臨床技術人員、採購經理和法規遵循專家進行了結構化訪談，以了解實際應用中的性能要求、檢驗挑戰和採購重點。此外，我們還對具有代表性的閥門結構進行了技術評估，包括操作機制、控制電子元件、材料相容性和失效模式分析。

整合策略需求和技術方向，指導比例閥的採購、開發和監管合規。

技術、監管和商業性觀點的整合揭示了比例閥領域相關人員通用的一系列關鍵挑戰。精確控制、臨床環境中可重複的性能以及合規性文件是製造商和原始設備製造商 (OEM) 必須滿足的核心技術要求。同時，供應鏈的穩定性、模組化整合能力和售後支援決定了閥門平台在不同醫療環境中的商業性可行性。

目錄

第1章：序言

第2章：調查方法

• 調查設計
• 研究框架
• 市場規模預測
• 數據三角測量
• 調查結果
• 調查的前提
• 研究限制

第3章執行摘要

• 首席主管觀點
• 市場規模和成長趨勢
• 2025年市佔率分析
• FPNV定位矩陣，2025
• 新的商機
• 下一代經營模式
• 產業藍圖

第4章 市場概覽

• 產業生態系與價值鏈分析
• 波特五力分析
• PESTEL 分析
• 市場展望
• 上市策略

第5章 市場洞察

• 消費者洞察與終端用戶觀點
• 消費者體驗基準
• 機會映射
• 分銷通路分析
• 價格趨勢分析
• 監理合規和標準框架
• ESG與永續性分析
• 中斷和風險情景
• 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療設備比例閥市場－閥型

• 流量控制
• 減壓
• 壓力釋放

第9章：醫療設備比例閥市場－依操作方式分類

• 電的
• 氣動驅動

第10章：按流量分類的醫療設備比例閥市場

• 0-100 公升/分鐘
• 100-500 公升/分鐘
• 超過 500 公升/分鐘

第11章：醫療設備比例閥市場：依應用領域分類

• 點滴幫浦
  • 注射器
  • 正位移
• 病患監測
  • 侵入性
  • 非侵入性
• 手術機器人
• 人工呼吸器
  • Icu
  • 攜帶式的

第12章：醫療設備比例閥市場：依最終用戶分類

• 診所
  • 全科
  • 專業醫療護理
• 居家醫療
• 醫院
  • 私人的
  • 民眾

第13章：醫療設備比例閥市場：依地區分類

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第14章：醫療設備比例閥市場：依類別分類

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第15章：醫療設備比例閥市場：依國家分類

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第16章：美國醫療設備比例閥市場

第17章：中國醫療設備比例閥市場

第18章 競爭情勢

• 市場集中度分析，2025年
  • 濃度比（CR）
  • 赫芬達爾-赫希曼指數 (HHI)
• 近期趨勢及影響分析，2025 年
• 2025年產品系列分析
• 基準分析，2025 年
• Beko Technologies AS
• Bosch Rexroth AG
• Burkert Werke GmbH & Co. KG
• Danfoss A/S
• Eaton Corporation plc
• Emerson Electric Co.
• Festo SE & Co. KG
• IMI PLC
• Moog Inc.
• Parker Hannifin Corporation
• Siemens Healthineers AG
• SMC Corporation

The Proportional Valves for Medical Devices Market was valued at USD 1.41 billion in 2025 and is projected to grow to USD 1.61 billion in 2026, with a CAGR of 14.97%, reaching USD 3.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.41 billion
Estimated Year [2026]	USD 1.61 billion
Forecast Year [2032]	USD 3.75 billion
CAGR (%)	14.97%

How proportional valves are redefining precision fluid control in medical devices and setting new performance expectations across clinical environments

Proportional valves increasingly occupy a pivotal role in modern medical device design, where nuanced control of fluid, gas, and pressure delivers measurable benefits for patient care and device reliability. Advances in actuator technologies and control electronics have elevated expectations for responsiveness, repeatability, and integration with closed-loop clinical systems. As clinical procedures demand finer precision and regulatory authorities require demonstrable safety and traceability, the functional profile of proportional valves has shifted from a component to a system-level enabler.

Design teams now prioritize valves that support deterministic control, low hysteresis, and predictable aging under sterilization and cyclic loads. At the same time, purchasing and operations functions weigh manufacturability, reproducibility, and logistics when selecting valve partners. This intersection of technical and commercial criteria creates new imperatives for cross-disciplinary coordination during product development, validation, and post-market vigilance.

Consequently, stakeholders across engineering, clinical affairs, and supply chain must align specifications, test protocols, and supplier engagement strategies earlier in the product lifecycle. This alignment reduces integration risk, shortens qualification timelines, and helps ensure that device performance objectives translate into reproducible clinical outcomes. The following sections unpack the shifts, segmentation perspectives, regional nuances, competitive dynamics, and recommended actions necessary to navigate this changing landscape with confidence.

Transformative shifts reshaping the proportional valve landscape driven by digital integration, regulatory rigor, and cross-disciplinary engineering convergence

The proportional valve landscape is undergoing multiple transformative shifts that are simultaneously technological, regulatory, and commercial. Digitally enabled control architectures are moving valves from analog actuators to cyber-physical elements, enabling software-driven calibration, remote diagnostics, and adaptive control loops that improve clinical responsiveness. Concurrently, miniaturization and material science advances are allowing valves to be integrated into smaller form factors while maintaining biocompatibility and sterilization resilience.

Regulatory focus has intensified on traceability, software lifecycle management, and human factors, prompting device manufacturers to demand greater documentation and verifiable validation from valve suppliers. This has accelerated strategic partnerships between valve developers and clinical OEMs, where co-development and shared validation plans de-risk integration and align timelines. From a supply perspective, rising emphasis on resilience has led to diversified sourcing strategies and emphasis on qualification of alternate vendors and second-source readiness.

At the same time, clinical practice trends-such as the growth of remote monitoring, expansion of home healthcare, and the increasing use of robotic-assisted procedures-are changing functional requirements. Valves must now perform reliably across a wider set of use cases and environmental conditions while interfacing seamlessly with digital health platforms. Taken together, these shifts demand that engineering, regulatory, and commercial teams rethink specifications, testing regimes, and supplier relationships to maintain competitive and clinical advantage.

Cumulative implications of United States tariff changes in 2025 on supply chains, sourcing strategies, and component redundancy for medical valve manufacturers

Tariff adjustments instituted by United States policy in 2025 have introduced tangible implications for the supply chains that underpin proportional valve production and distribution. Component sourcing strategies are under renewed scrutiny as cost differentials emerge for certain imported parts, prompting manufacturers to reassess BOM allocations, nearshoring opportunities, and supplier contractual terms to preserve cost predictability. The increased cost pressure on specific imported subcomponents has also affected negotiation dynamics with strategic suppliers, motivating longer-term agreements that include shared risk provisions and joint inventory buffering.

Beyond direct input cost impacts, tariff shifts have encouraged manufacturers to revisit their qualification procedures for alternate vendors and expedite validation pathways for domestically sourced or tariff-exempt components. Procurement teams are prioritizing dual-sourcing and capacity audits to mitigate the risk of supply interruptions. At the same time, engineering organizations are exploring design adaptations that reduce dependency on affected components without compromising clinical performance or regulatory compliance, thereby preserving device safety and functionality.

Manufacturers with vertically integrated supply models or diversified supplier ecosystems experience more predictable outcomes, while those with concentrated supplier exposure face higher cadence of commercial and technical remediation. In all cases, the practical response has combined proactive supplier engagement, scenario planning, and iterative design reviews to absorb tariff-related impacts while preserving product timelines and clinical integrity.

Actionable segmentation insights linking valve types, application niches, actuation modes, end-user settings, and flow rate classes to clinical performance

A segmentation-centric view clarifies how design intent, clinical context, and end-user environment shape technical and commercial decisions for proportional valves. Based on valve type, design teams commonly differentiate among flow control, pressure reducing, and pressure relief valves, each carrying distinct performance priorities such as linearity, response time, and overpressure behavior. These functional differences influence materials choice, control algorithm complexity, and validation protocols, and they determine the kinds of failure modes that must be mitigated in clinical settings.

Based on application, proportional valve selection is shaped by use-case specifics including infusion pumps, patient monitoring systems, surgical robots, and ventilators. Infusion pump contexts further require attention to syringe versus volumetric platforms, each with unique flow dynamics and contamination control considerations. Patient monitoring applications split into invasive and non-invasive modalities, which impose divergent requirements on sterilizability and interface integrity. Ventilator usage is differentiated by ICU and portable deployments, prompting different trade-offs between peak flow capabilities, energy consumption, and ruggedization.

Based on actuation type, the landscape bifurcates into electric actuation and pneumatic actuation, a choice that affects power management, control latency, and mechanical complexity. Based on end user, deployment environments span clinics, home healthcare, and hospitals, with clinics divided into general practice and specialty settings and hospitals categorized as private or public; each environment drives distinct procurement cycles, service models, and lifecycle expectations. Based on flow rate, technical requirements map to categories such as 0-100 L/min, 100-500 L/min, and above 500 L/min, which influence valve sizing, thermal management, and throughput testing. By viewing these segments in concert, decision-makers can align component selection, validation resources, and commercial strategies with the clinical and operational realities they intend to serve.

Regional dynamics and priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific driving distribution choices and regulatory alignment

Regional dynamics exert a powerful influence over regulatory timing, supplier ecosystems, and clinical adoption pathways for proportional valves. In the Americas, procurement cycles often prioritize supply resilience, clinical evidence packages, and transactional transparency; this environment favors suppliers that can demonstrate robust quality systems, responsive technical support, and reliable logistics. Meanwhile, Europe, Middle East & Africa typically demands stringent conformity with regional regulatory frameworks and harmonized technical documentation, driving suppliers to maintain comprehensive compliance records and to invest in post-market surveillance capabilities.

Asia-Pacific presents a heterogeneous environment in which rapid clinical adoption in certain markets coexists with diverse regulatory regimes and manufacturing ecosystems. The region often offers advanced manufacturing capabilities and specialized suppliers, which can accelerate innovation cycles but require careful qualification to ensure consistent global compliance. Distribution strategies must therefore be tailored to regional reimbursement structures, hospital procurement behaviors, and local service expectations.

Across all regions, successful commercialization depends on aligning product design with local clinical practices and regulatory expectations, investing in regionally appropriate training and support, and structuring supply chain redundancy that reflects geopolitical and tariff-related exposures. Coordinated regional strategies that recognize these differences will better position manufacturers to capture clinical acceptance and operational reliability across jurisdictions.

Competitive intelligence on leading proportional valve developers emphasizing product differentiation, supply resilience, strategic partnerships, lifecycle support

Competitive dynamics among companies that develop or integrate proportional valves hinge on the ability to combine technical differentiation with operational reliability and scalable support. Leading developers emphasize precision control, low-power actuation options, and validated materials that support sterilization and biocompatibility requirements. Equally important is the readiness of suppliers to provide detailed technical data packages, software interfaces, and long-term lifecycle support, which ease integration burdens for OEMs and reduce regulatory friction.

Supply resilience is a decisive commercial attribute; companies that have invested in diversified sourcing, inventory visibility, and production redundancy tend to better withstand logistical and policy shocks. Strategic partnerships and co-development agreements between valve specialists and device OEMs are increasingly common, as they enable earlier alignment on interfaces, testing regimes, and shared validation data. Additionally, companies that offer configurable platforms with modular control electronics and standardized communication protocols gain traction by shortening time-to-integration and supporting iterative product improvements.

Service and aftermarket capabilities - including calibration support, field diagnostics, and component traceability - further distinguish competitors. Firms that combine robust product engineering with predictable delivery, responsive technical support, and transparent quality documentation earn preference from hospitals and clinics that must minimize downtime and maintain regulatory compliance. Investors and strategic buyers will therefore assess firms on both innovation and operational execution.

Targeted operational, procurement, and R&D actions for medical device leaders to accelerate integration of proportional valve innovations into clinical products

Industry leaders must translate technical insight into concrete operational and strategic actions to secure clinical adoption and commercial resilience. First, align engineering specifications with the highest-priority clinical use cases by formalizing cross-functional requirement documents that incorporate input from clinicians, procurement, and quality assurance. This reduces late-stage redesign and accelerates validation. Second, implement dual-sourcing or qualified second-source strategies for critical components and validate alternatives early through expedited qualification protocols to reduce single-source exposure.

Third, invest in modular control architectures and standardized communication interfaces to simplify integration with device electronics and software ecosystems. This approach enables faster customization for different applications and eases regulatory change management. Fourth, strengthen supplier partnerships through co-development agreements that share validation responsibilities and create mutually aligned roadmaps, thereby reducing integration risk and improving time-to-deployment.

Fifth, embed post-market vigilance and remote diagnostics into valve offerings to provide customers with actionable performance data and reduce field-service burdens. Sixth, incorporate tariff scenario planning and cost-to-serve analyses into procurement cycles to manage policy-driven cost variability. Finally, prioritize training, documentation, and local support models that reflect regional regulatory and clinical practice differences so that deployment is smooth and adoption can scale across varied healthcare settings.

Robust mixed-method research approach combining technical validation, stakeholder interviews, and supply chain tracing to ensure accuracy and actionable insights

The research approach underpinning this analysis combined mixed methods to ensure technical rigor and practical relevance. Primary research included structured interviews with device engineers, clinical technologists, procurement leaders, and regulatory affairs professionals to capture real-world performance requirements, validation challenges, and procurement priorities. These interviews were supplemented by technical evaluations of representative valve architectures, including actuation mechanisms, control electronics, materials compatibility, and failure mode assessments.

Secondary research synthesized regulatory guidance, standards references, and publicly available technical documentation to contextualize design and compliance imperatives. Supply chain tracing and vendor capability mapping were employed to identify common concentrations of risk and to evaluate second-source feasibility. Patent landscape reviews and product literature analysis provided insight into differentiating innovations and common platform approaches.

Data triangulation and validation workshops ensured that findings reflected consensus across stakeholder groups and that technical assertions were tested against practical integration scenarios. Segmentation mapping linked functional requirements to end-user contexts and flow-rate classes, enabling prescriptive advice that aligns engineering choices with clinical and commercial constraints. This layered methodology provides a defensible foundation for decision-making while remaining adaptable to new technical or policy developments.

Synthesis of strategic imperatives and technological vectors that will guide procurement, development, and regulatory engagement for proportional valve adoption

The synthesis of technical, regulatory, and commercial perspectives reveals a convergent set of imperatives for proportional valve stakeholders. Precision control, reproducible performance under clinical conditions, and documented compliance form the core technical expectations that manufacturers and OEMs must meet. At the same time, supply resilience, modular integration capabilities, and post-market support determine the commercial viability of valve platforms in diverse healthcare environments.

Strategic responses that align design decisions with application-specific needs, validate alternative sourcing early, and invest in digital control and diagnostics will reduce integration risk and enhance clinical outcomes. Regional nuances in procurement behavior and regulatory frameworks necessitate tailored go-to-market approaches that respect local requirements while preserving global interoperability. Companies that combine product excellence with dependable delivery, transparent quality documentation, and proactive customer support will gain preferential access to hospital and clinic procurement decisions.

In short, successful adoption of proportional valve technologies requires coordinated action across engineering, quality, procurement, and clinical teams. When these functions work in tandem, organizations can convert technical capabilities into predictable clinical performance and operational continuity, thereby strengthening both patient outcomes and commercial positioning.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Proportional Valves for Medical Devices Market, by Valve Type

• 8.1. Flow Control
• 8.2. Pressure Reducing
• 8.3. Pressure Relief

9. Proportional Valves for Medical Devices Market, by Actuation Type

• 9.1. Electric Actuation
• 9.2. Pneumatic Actuation

10. Proportional Valves for Medical Devices Market, by Flow Rate

• 10.1. 0-100 L/Min
• 10.2. 100-500 L/Min
• 10.3. Above 500 L/Min

11. Proportional Valves for Medical Devices Market, by Application

• 11.1. Infusion Pumps
  • 11.1.1. Syringe
  • 11.1.2. Volumetric
• 11.2. Patient Monitoring
  • 11.2.1. Invasive
  • 11.2.2. Non-Invasive
• 11.3. Surgical Robots
• 11.4. Ventilators
  • 11.4.1. Icu
  • 11.4.2. Portable

12. Proportional Valves for Medical Devices Market, by End User

• 12.1. Clinics
  • 12.1.1. General Practice
  • 12.1.2. Specialty
• 12.2. Home Healthcare
• 12.3. Hospitals
  • 12.3.1. Private
  • 12.3.2. Public

13. Proportional Valves for Medical Devices Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Proportional Valves for Medical Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Proportional Valves for Medical Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Proportional Valves for Medical Devices Market

17. China Proportional Valves for Medical Devices Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. Beko Technologies A.S.
• 18.6. Bosch Rexroth AG
• 18.7. Burkert Werke GmbH & Co. KG
• 18.8. Danfoss A/S
• 18.9. Eaton Corporation plc
• 18.10. Emerson Electric Co.
• 18.11. Festo SE & Co. KG
• 18.12. IMI PLC
• 18.13. Moog Inc.
• 18.14. Parker Hannifin Corporation
• 18.15. Siemens Healthineers AG
• 18.16. SMC Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 13. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW CONTROL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW CONTROL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE REDUCING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE REDUCING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE REDUCING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE RELIEF, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE RELIEF, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRESSURE RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ELECTRIC ACTUATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ELECTRIC ACTUATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ELECTRIC ACTUATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PNEUMATIC ACTUATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PNEUMATIC ACTUATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PNEUMATIC ACTUATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 0-100 L/MIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 0-100 L/MIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 0-100 L/MIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 100-500 L/MIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 100-500 L/MIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY 100-500 L/MIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ABOVE 500 L/MIN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ABOVE 500 L/MIN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ABOVE 500 L/MIN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY NON-INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY NON-INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ICU, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ICU, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ICU, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GENERAL PRACTICE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GENERAL PRACTICE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GENERAL PRACTICE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 88. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 89. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 90. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 91. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 92. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 93. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 94. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 95. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 96. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 97. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 98. AMERICAS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 99. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 101. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 102. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 103. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 104. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 105. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 106. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 107. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 108. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 109. NORTH AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 110. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 111. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 112. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 113. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 114. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 115. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 116. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 117. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 118. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 119. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 120. LATIN AMERICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 132. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 133. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 134. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 135. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 136. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 137. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 138. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 139. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 140. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 141. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 142. EUROPE PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 143. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 144. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 145. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 146. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 147. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 148. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 149. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 150. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 151. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 152. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 153. MIDDLE EAST PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 154. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 155. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 156. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 157. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 158. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 159. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 160. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 161. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 162. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 163. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 164. AFRICA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 165. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 166. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 167. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 168. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 169. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 170. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 171. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 172. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 173. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 174. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 175. ASIA-PACIFIC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 176. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 177. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 178. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 179. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 180. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 181. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 182. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 183. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 184. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 185. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 186. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 187. ASEAN PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 188. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 189. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 190. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 191. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 192. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 193. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 194. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 195. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 196. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 197. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 198. GCC PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 199. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 200. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 201. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 202. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 203. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 204. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 205. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 206. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 207. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 208. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 209. EUROPEAN UNION PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 210. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 211. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 212. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 213. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 214. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 215. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 216. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 217. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 218. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 219. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 220. BRICS PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 221. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 222. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 223. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 224. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 225. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 226. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 227. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 228. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 229. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 230. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 231. G7 PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 232. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 233. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 234. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 235. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 236. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 237. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 238. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 239. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 240. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 241. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 242. NATO PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 243. GLOBAL PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 244. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 245. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 246. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 247. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 248. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 249. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 250. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 251. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 252. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 253. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 254. UNITED STATES PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
• TABLE 255. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 256. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
• TABLE 257. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY ACTUATION TYPE, 2018-2032 (USD MILLION)
• TABLE 258. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
• TABLE 259. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 260. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
• TABLE 261. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
• TABLE 262. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, 2018-2032 (USD MILLION)
• TABLE 263. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 264. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
• TABLE 265. CHINA PROPORTIONAL VALVES FOR MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)